Patent details
EP2841575 Title: ANTI-GCC ANTIBODY MOLECULES AND USE OF SAME TO TEST FOR SUSCEPTIBILITY TO GCC-TARGETED THERAPY
Basic Information
- Publication number:
- EP2841575
- PCT Application Number:
- US2013038542
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP137820619
- PCT Publication Number:
- WO2013163633
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-GCC ANTIBODY MOLECULES AND USE OF SAME TO TEST FOR SUSCEPTIBILITY TO GCC-TARGETED THERAPY
- French Title of Invention:
- MOLÉCULES D'ANTICORPS ANTI-GCC ET LEUR UTILISATION EN VUE DE TESTER LA SENSIBILITÉ À UNE THÉRAPIE CIBLÉE SUR LA GCC
- German Title of Invention:
- ANTI-GCC-ANTIKÖRPERMOLEKÜLE UND VERWENDUNG DAVON FÜR EINEN TEST AUF EMPFÄNGLICHKEIT FÜR EINE GCC-GEZIELTE THERAPIE
- SPC Number:
Dates
- Filing date:
- 27/04/2013
- Grant date:
- 26/06/2019
- EP Publication Date:
- 04/03/2015
- PCT Publication Date:
- 31/10/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/06/2019
- EP B1 Publication Date:
- 26/06/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 27/04/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/11/2021
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)
History of Owners
- From:
- 19/06/2019
- To:
- 24/11/2021
- Name:
- Millennium Pharmaceuticals, Inc.
- Address:
- 40 Landsdowne Street, Cambridge, MA 02139, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 11/09/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- O'KEEFE, Theresa, L.
- Address:
- United States (US)
2
- Name:
- FRANK, Helen, Alison
- Address:
- United States (US)
3
- Name:
- MCDONALD, Alice, A.
- Address:
- United States (US)
Priority
- Priority Number:
- 201261639376 P
- Priority Date:
- 27/04/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07K 16/40; G01N 33/574;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2021/13
- Publication date:
- 02/12/2021
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
- Issue number:
- 201926
- Publication date:
- 26/06/2019
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20210000495A
- Date Registered:
- 24/11/2021
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- Baker & McKenzie
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/10/2025
- Annual Fee Number:
- 13
- Annual Fee Amount:
- 180 Euro
- Penalty Fee Amount:
- 20 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 20/03/2024
- Last Annual Fee Paid Number:
- 12
- Last Annual Fee Paid Amount:
- 165 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|---|---|
| 24/11/2021 | Request For Change | 7 |
| 24/09/2019 | Outgoing Correspondence | 1 |
| 11/09/2019 | Power Of Attorney | 1 |
| 24/11/2021 | Outgoing Correspondence | 1 |